AMS.L Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 18:35):

Stats
Šios dienos apimtis	203 266
Vidutinė apimtis	622 690
Rinkos kapitalizacija	403.09M
EPS	£0 ( 2024-03-16 )
Last Dividend	£1.510 ( 2023-05-18 )
Next Dividend	£0 ( N/A )
P/E	26.54
ATR14	£0.423 (0.23%)

Tūris Koreliacija

Ilgas: 0.05 (neutral)

Trumpas: -0.42 (neutral)

Signal:(51.188) Neutral

Advanced Medical Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
EJFI.L	0.861
PSON.L	0.855
VSL.L	0.845
ALL.L	0.841
NAIT.L	0.84
WIN.L	0.837
MIG.L	0.836
BEZ.L	0.836
LXI.L	0.834
DHSD.L	0.833

10 Labiausiai neigiamai susiję koreliacijos
TFG.L	-0.877
UD04.L	-0.855
OCTP.L	-0.851
7DIG.L	-0.836
UAI.L	-0.835
FAN.L	-0.818
CALL.L	-0.805

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Advanced Medical Koreliacija - Valiuta/Žaliavos

0.10
( neutral )

0.28
( neutral )

0.00
( neutral )

0.36
( neutral )

0.24
( neutral )

-0.17
( neutral )

Advanced Medical Finansinės ataskaitos

Annual	2023
Pajamos:	£126.21M
Bruto pelnas:	£63.73M (50.49 %)
EPS:	£0.0736

FY	2023
Pajamos:	£126.21M
Bruto pelnas:	£63.73M (50.49 %)
EPS:	£0.0736

FY	2022
Pajamos:	£124.33M
Bruto pelnas:	£68.62M (55.19 %)
EPS:	£0.0942

FY	2021
Pajamos:	£108.60M
Bruto pelnas:	£61.07M (56.23 %)
EPS:	£0.0813

Financial Reports:

No articles found.

Advanced Medical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0.640 (N/A)	£0 (N/A)	£0 (N/A)	£1.510 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

Advanced Medical Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.66 - Stable (33.11%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	£0.380	2011-05-11
Last Dividend	£1.510	2023-05-18
Next Dividend	£0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	26	--
Total Paid Out	£14.14	--
Avg. Dividend % Per Year	0.41%	--
Score	4.25	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	6.66
Div. Directional Score	9.41	--

Next Divdend (Est)
(2024-09-23)

£0 Estimate 3.72 %

Dividend Stability

0.30 Very Poor

Dividend Score

4.25

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2011	£0.525	0.72%
2012	£0.475	0.51%
2013	£0.540	0.85%
2014	£0.630	0.57%
2015	£0.730	0.58%
2016	£0.850	0.48%
2017	£0.970	0.44%
2018	£1.170	0.38%
2019	£1.400	0.51%
2020	£1.550	0.53%
2021	£1.780	0.73%
2022	£2.01	0.61%
2023	£1.510	0.57%
2024	£0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SBRE.L	Dividend Knight	2023-08-17	Semi-Annually	7	2.15%
HSX.L	Dividend Knight	2023-08-17	Annually	18	1.61%
BDEV.L	Dividend King	2023-09-28	Semi-Annually	32	2.43%
WHR.L	Dividend Knight	2023-09-07	Quarterly	7	2.99%
MYI.L	Dividend King	2023-07-06	Quarterly	52	2.04%
ECEL.L	Dividend Knight	2023-09-14	Annually	10	2.87%
SN.L	Dividend Knight	2023-10-05	Semi-Annually	32	1.26%
IPU.L	Dividend Knight	2023-08-03	Quarterly	37	2.34%
BRK.L	Dividend Knight	2023-09-21	Semi-Annually	20	2.12%
PCTN.L	Dividend Knight	2023-08-03	Quarterly	19	2.32%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.126	1.500	7.48	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0549	1.200	8.17	9.80	[0 - 0.3]
returnOnEquityTTM	0.0653	1.500	-0.386	-0.579	[0.1 - 1]
payoutRatioTTM	0.301	-1.000	6.99	-6.99	[0 - 1]
currentRatioTTM	5.67	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	4.00	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	2.79	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.00403	-1.500	9.93	-10.00	[0 - 0.6]
interestCoverageTTM	11.88	1.000	6.71	6.71	[3 - 30]
operatingCashFlowPerShareTTM	0.0666	2.00	9.98	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0212	2.00	9.99	10.00	[0 - 20]
debtEquityRatioTTM	0.00477	-1.500	9.98	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.505	1.000	4.92	4.92	[0.2 - 0.8]
operatingProfitMarginTTM	0.142	1.000	9.16	9.16	[0.1 - 0.6]
cashFlowToDebtRatioTTM	12.42	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.436	0.800	-0.424	-0.339	[0.5 - 2]
Total Score				12.17

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	25.37	1.000	7.54	0	[1 - 100]
returnOnEquityTTM	0.0653	2.50	-0.248	-0.579	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0212	2.00	9.99	10.00	[0 - 30]
dividendYielPercentageTTM	1.189	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.0666	2.00	9.98	10.00	[0 - 30]
payoutRatioTTM	0.301	1.500	6.99	-6.99	[0 - 1]
pegRatioTTM	55.77	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.115	1.000	9.64	0	[0.1 - 0.5]
Total Score				6.66

Advanced Medical

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, France, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The Surgical segment offers topical tissue adhesives for wound closure and sealing under the LiquiBand brand; sutures and collagen-based products for the surgical and dental markets under the RESORBA brand; collagens; and laparoscopic device used to fix hernia meshes placed inside the body under the LiquiBand Fix8 brand, as well as internal sealants under the Seal-G/Seal-G MIST brand. The Woundcare segment provides wound care platform technologies, which include alginates, foams, films, fibres, hydrogels, antimicrobial dressings, and hydrocolloids, as well as wound care products under the ActivHeal brand. Advanced Medical Solutions Group plc was incorporated in 1991 and is headquartered in Winsford, the United Kingdom.